Factor xia in complex with the inhibitor methyl [(5E,8S)-8-[(4S)-4-(3- chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H- 12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-YL]CARBAMATE

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 34% strand (DSSP).

Ligands and binding sites

• NR7 · Methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12, 9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate · ligand · chains A
• SO4 · Sulfate ion · ion · chains A
• EDO · 1,2-ethanediol · additive · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

• 5QQP · FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl… · the same entry in another collection · chain A against A, TM-score 1.00
• P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

• Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
• Every structure of UniProt P03951
• Elsewhere: RCSB PDB 5QQP · PDBe 5QQP · UniProt P03951